Skip to content

Developing Screening Clinical Breast Examination Implementation Strategies in Nigeria

Developing an Approach to Implementing Breast Cancer Screening Using Clinical Breast Exam in the Primary Health Centers of Abuja, Nigeria

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07080515
Enrollment
62
Registered
2025-07-23
Start date
2025-09-01
Completion date
2026-03-26
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Detection

Brief summary

The goal of this observational study is to engage with multilevel stakeholders to collaboratively and to systematically develop a suite of strategies for implementing breast cancer screening using clinical breast examination (CBE) in the primary health centers of Abuja, Nigeria. The main questions it aims to answer are: What barriers and facilitators exist to conducting screening CBE in Abuja's primary care setting and what implementation strategies would support CBE in primary care clinics? Participants will: * Allow observation of study clinic workflows * Participate in interviews and focus group discussions regarding screening CBE implementation

Interventions

None listed

Sponsors

Yale University
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH
University of Witwatersrand, South Africa
CollaboratorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

In order to be eligible for inclusion in the focus group discussions held with screening CBE "adopters" and "implementers," an individual must meet all of the following criteria: 1. Be an employee or volunteer working at a participating PHC OR Be an employee or volunteer working at Nigeria's Ministry of Health OR Be an employee or volunteer working with a non-governmental organization that performs breast cancer related activities within the catchment area of a participating PHC 2. Be willing to commit to keeping the content of focus group discussions confidential In order to be eligible for inclusion in the focus group discussions held with screening CBE "recipients," an individual must meet all of the following criteria: 1. Be female 2. Be between the ages of 40 and 65 years 3. Be living within the catchment area of a participating PHC 4. Be willing to commit to keeping the content of focus group discussions confidential

Design outcomes

Primary

MeasureTime frameDescription
Intervention Domain Characteristics1 yearCharacteristics of routine clinical breast examination itself that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.
Inner Setting Domain Characteristics1 yearCharacteristics of the primary care clinics that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.
Outer Setting Domain Characteristics1 yearCharacteristics of both the community surrounding the clinics and the district-wide health system that are potential barriers and facilitators to screening implementation, , emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.
Individuals Domain Characteristics1 yearCharacteristics of individuals involved in screening that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.
Implementation Domain Characteristics1 yearCharacteristics of activities and strategies used to implement screening that are potential barriers and facilitators to screening implementation, emerging from thematic analysis of qualitative data organized according to the Consolidated Framework for Implementation Research.

Countries

Nigeria

Contacts

PRINCIPAL_INVESTIGATORDaniel O'Neil, MD, MPH

Yale University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026